Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome
Anavex now has open INDs in all three core indications: Alzheimer's disease, Rett syndrome, and Fragile X syndrome
Anavex now has open INDs in all three core indications: Alzheimer's disease, Rett syndrome, and Fragile X syndrome